Petesicatib

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NamePetesicatib
Drug Alias NamePetesicatib - RocheRG-7625RO-5459072
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin S inhibitors
TargetsCathepsin S
Therapy Area/IndicationsCeliac DiseaseSjogren's Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandPortugal +[7] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsCeliac DiseaseSjogren's Syndrome

Other Information

ATC CodeN/A
Related LinksN/A